AI assistant
DEXCOM INC — Director's Dealing 2016
Sep 14, 2016
30198_dirs_2016-09-14_a9590764-2b25-42bd-b423-5de824a87406.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2014-05-08
Reporting Person: KAHN BARBARA (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-05-08 | Common Stock | S | 7500.0 | $30.1139 | Disposed | 4791 | Direct |
| 2016-09-12 | Common Stock | S | 5000.0 | $92.9023 | Disposed | 24304 | Indirect |
Footnotes
F1: Inadvertently filed late due to an administrative error.
F2: Included in this number are 4,791 unvested restricted stock units which were granted on May 25, 2016 and shall vest on May 25, 2017.
F3: This transaction was executed in multiple trades at prices ranging from $92.90 to $92.95. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
F4: Shares are held by the Barbara Kahn TTEE Barbara Kahn Rev TRT DTD 6/26/96 & Robert Meyer TTEE Robert Meyer Rev Trst DTD 6/26/96, with respect to which the reporting person is a trustee.